| Product Code: ETC6755887 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, China continued to rely on key suppliers such as the USA, India, Japan, Germany, and Belgium for valganciclovir imports. The market showed low concentration with a Herfindahl-Hirschman Index (HHI) indicating a competitive landscape. However, the compound annual growth rate (CAGR) from 2020 to 2024 was negative at -7.29%, reflecting a challenging environment. Additionally, the growth rate from 2023 to 2024 saw a further decline at -13.39%, suggesting a potential slowdown in demand or other market factors affecting import shipments of valganciclovir into China.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Valganciclovir Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Valganciclovir Market Revenues & Volume, 2021 & 2031F |
3.3 China Valganciclovir Market - Industry Life Cycle |
3.4 China Valganciclovir Market - Porter's Five Forces |
3.5 China Valganciclovir Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 China Valganciclovir Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 China Valganciclovir Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cytomegalovirus (CMV) infections in China |
4.2.2 Growing awareness about the effectiveness of valganciclovir in treating CMV infections |
4.2.3 Rising healthcare expenditure and improving healthcare infrastructure in China |
4.3 Market Restraints |
4.3.1 High cost associated with valganciclovir treatment |
4.3.2 Stringent regulatory requirements for approval and marketing of pharmaceutical products in China |
4.3.3 Competition from alternative treatments for CMV infections |
5 China Valganciclovir Market Trends |
6 China Valganciclovir Market, By Types |
6.1 China Valganciclovir Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 China Valganciclovir Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 China Valganciclovir Market Revenues & Volume, By Powder, 2021- 2031F |
6.1.4 China Valganciclovir Market Revenues & Volume, By Tablet, 2021- 2031F |
6.2 China Valganciclovir Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 China Valganciclovir Market Revenues & Volume, By Adults, 2021- 2031F |
6.2.3 China Valganciclovir Market Revenues & Volume, By Children, 2021- 2031F |
7 China Valganciclovir Market Import-Export Trade Statistics |
7.1 China Valganciclovir Market Export to Major Countries |
7.2 China Valganciclovir Market Imports from Major Countries |
8 China Valganciclovir Market Key Performance Indicators |
8.1 Number of CMV cases diagnosed annually in China |
8.2 Adoption rate of valganciclovir as a treatment for CMV infections in China |
8.3 Number of healthcare facilities offering valganciclovir treatment |
9 China Valganciclovir Market - Opportunity Assessment |
9.1 China Valganciclovir Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 China Valganciclovir Market Opportunity Assessment, By Application, 2021 & 2031F |
10 China Valganciclovir Market - Competitive Landscape |
10.1 China Valganciclovir Market Revenue Share, By Companies, 2024 |
10.2 China Valganciclovir Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here